ahlam1399
04-06-2016, 07:25 PM
BRIEF-Fitch says FDA biosimilar label guidance supportive for growth
* Believe biosimilar market could eventually evolve to a point where it operates like traditional small-molecule generic drug markethttp://feeds.feedburner.com/~ff/reuters/bondsNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/bondsNews?a=0sAOBLHQVsc:MSXAaGvbahw:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/bondsNews?i=0sAOBLHQVsc:MSXAaGvbahw:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/bondsNews?a=0sAOBLHQVsc:MSXAaGvbahw:F7zBnMyn0Lo) http://feeds.feedburner.com/~ff/reuters/bondsNews?i=0sAOBLHQVsc:MSXAaGvbahw:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/bondsNews?a=0sAOBLHQVsc:MSXAaGvbahw:V_sGLiPBpWU)
http://feeds.feedburner.com/~r/reuters/bondsNews/~4/0sAOBLHQVsc
* Believe biosimilar market could eventually evolve to a point where it operates like traditional small-molecule generic drug markethttp://feeds.feedburner.com/~ff/reuters/bondsNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/bondsNews?a=0sAOBLHQVsc:MSXAaGvbahw:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/bondsNews?i=0sAOBLHQVsc:MSXAaGvbahw:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/bondsNews?a=0sAOBLHQVsc:MSXAaGvbahw:F7zBnMyn0Lo) http://feeds.feedburner.com/~ff/reuters/bondsNews?i=0sAOBLHQVsc:MSXAaGvbahw:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/bondsNews?a=0sAOBLHQVsc:MSXAaGvbahw:V_sGLiPBpWU)
http://feeds.feedburner.com/~r/reuters/bondsNews/~4/0sAOBLHQVsc